Sam Waksal's IPO biotech plans
Share

Sam Waksal's IPO biotech plans

CNBC's Meg Tirrell, and Sam Waksal, Kadmon founder & chairman, discuss plans to take the biotech company public.
01:38
Tue, Jan 13 20158:31 AM EST